Legal drugs are a big business, with over 200 companies each worth at least US$200 million, and 7 worth over $100 billion. Medicines are one of the few types of products I find advertised about equally in the US and in Hong Kong (otherwise I think of the US as mostly advertising cars and consumer goods while Hong Kong advertises more educational and financial services). Many pharma companies are defined by their unique intellectual property in specific drugs, or processes in making generic drugs, and this certainly is a sector where understanding how to value such intellectual property is an advantage.
With more than 1,200 international actors from 35+ countries
, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences . BioFIT is also the marketplace for pre-seed, seed and Series A investment in Life Sciences.